We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...

Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Maplebear in a research note issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...

Cantor Fitzgerald initiated coverage on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a research ...

2025年1月8日星期三 - Cantor Fitzgerald给予SentinelOne Inc (NYSE: S)增持评级，并将这家网络安全公司的股票目标价设定为30.00美元。Cantor ...

The “Blood Diamond” actor said Hollywood still has a long way to go toward diversity in the entertainment industry.

In a recent blog post, OpenAI CEO Sam Altman said that as OpenAI continues to advance it has moved beyond research to product ...

Cantor Fitzgerald analysts initiated coverage on Check Point Software (NASDAQ:CHKP) with a Neutral rating and a $200 price ...

周二，Cantor Fitzgerald对Anteris Technologies Global (NASDAQ:AVR)启动覆盖，给予增持评级，目标价为$9.00。该公司分析师列举了几个看好该公司的理由，Anteris Technologies经营临床阶段结构性心脏板块业务。该公司专注于开发和商业化旨在提高主动脉瓣狭窄患者生活质量的医疗设备。

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...

Cantor Fitzgerald analyst Ross Osborn initiated coverage of Anteris Technologies (AVR) with an Overweight rating and $9 price target Anteris ...